Immunomedics Inc. (IMMU) released that its complete responses in patients by means of metastatic triple-negative breast cancer following Sacituzumab Govitecan treatment. Amid 49 patients with metastatic triple-negative breast cancer assessed for reply to treatments by means of sacituzumab govitecan in a mid-stage clinical study, 31 percent, or 15 patients, showed a decrease in tumor size of 30 percent or more. They comprise two patients with complete response. Adding the 22 patients by means of responses among lower than 30 percent tumor shrinkage and less than 20% tumor increase, the disease control rate was 76%.
GoPro, Inc. (GPRO) released the availability of its new HERO+ LCD camera. Capturing life-like HD 1080p60 video as well as 8MP photos, the HERO+ LCD features a convenient stroke display for easy shot framing, settings control, and access to an all-new in-camera video trimming feature. Similar to the entry-level HERO, the HERO+ LCD is built directly into its waterproof housing. The ease of this all-in-one design at the present combines with enlarged features to make capturing life’s memorable moments easier than ever.
Corning Inc. (GLW) released Corning Lotus(TM) NXT Glass, its third-generation glass composition for high-performance displays. The firm will showcase this newest innovation in booth #733 at the Society for Information Display`s (SID) Display Week in San Jose, Calif., June 2-4.